Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium

Summary by The Standard-Journal
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun 8, 2026-
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

The Standard-JournalThe Standard-Journal

Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jun 8, 2026-

·Milton, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Standard-Journal broke the news in Milton, United States on Monday, June 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

South San Francisco icon

South San Francisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal